Skip to main content
SpringerLink
Log in

Meropenem: a new carbapenem with potential for treating bacterial meningitis

  • New Drugs and Therapeutic
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Wiseman LR, Wagstaff AJ, Brogden RN, et al. Meropenem: a review of its antibacterial activity, pharmacokinetic properties and clinical efficacy. Drugs 1995 50(1): 73–101

    Article  PubMed  CAS  Google Scholar 

  2. British National Formulary No. 29. London: The Pharmaceutical Press. 1995

  3. New Ethicals Compendium. Auckland: Adis International Ltd, 1994

  4. Treatment of bacterial meningitis relies on early identification and antibacterial therapy. Drug Ther Perspect 1994 Nov 28; 4(11): 8–10

    Article  Google Scholar 

  5. Buckley MM, Brogden RN, Barradell LB, et al. Imipenem/cilastatin: a reappraisal of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 1992; 44(3): 408–44

    Article  PubMed  CAS  Google Scholar 

  6. Condon RE, Walker AP, Sirinek KR, et al. Meropenem versus tobramycin plus clindamycin for treatment of intraabdominal infections: results of a prospective, randomized, double-blind clinical trial. Clin Infect Dis 1995 Sep; 21: 544–50

    Article  PubMed  CAS  Google Scholar 

  7. Huizinga WKJ, Warren BL, Baker LW, et al. Antibiotic monotherapy with meropenem in the surgical management of intra-abdominal infections. J Antimicrob Chemother 1995 Jul; 36 Suppl. A: 179–89

    Article  PubMed  CAS  Google Scholar 

  8. Meropenem Study Group of Leuven, London and Nijmegen. Equivalent efficacies of meropenem and ceftazidime as empirical monotherapy of febrile neutropenic patients. J Antimicrob Chemother 1995; 36: 185–200

    Article  Google Scholar 

  9. Hamacher J, Vogel F, Lichey J. Treatment of acute bacterial exacerbations of chronic obstructive pulmonary disease in hospitalised patients — a comparison of meropenem and imipenem/cilastatin. J Antimicrob Chemother 1995 Jul; 36 Suppl. A: 121–33

    Article  PubMed  CAS  Google Scholar 

  10. Mouton JW, van den Anker. Meropenem clinical pharmacokinetics. Clin Pharmacokinet 1995 Apr; 28(4): 275–86

    Article  PubMed  CAS  Google Scholar 

  11. Sieger B, Geckler R. A comparison of meropenem and ceftazidime lus tobramycin in the treatment of hospital-acquired lower respiratory tract infections [abstract]. In: 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy 1993: 236

  12. Romanelli G, Cravarezza P, Italian Intramuscular Meropenem Study Group. Intramuscular meropenem in the treatment of bacterial infections of the urinary and lower respiratory tracts. J Antimicrob Chemother 1995 Jul; 36 Suppl. A: 109–19

    Article  PubMed  CAS  Google Scholar 

  13. Norrby SR, Newell PA, Faulkner KL, et al. Safety profile of meropenem: international clinical experience based on the first 3125 patients treated with meropenem. J Antimicrob Chemother 1995 Jul; 36 Suppl. A: 207–23

    Article  PubMed  CAS  Google Scholar 

  14. Mouton YJ, Beuscart C, Meropenem Study Group. Empirical monotherapy with meropenem in serious bacterial infections. J Antimicrob Chemother 1995 Jul; 36 Suppl. A: 145–56

    Article  PubMed  CAS  Google Scholar 

  15. Choice of antibacterial drugs. Mett lett 1994 Jun 24; 36(925): 53–60

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meropenem: a new carbapenem with potential for treating bacterial meningitis. Drugs Ther. Perspect 6, 1–5 (1995). https://doi.org/10.2165/00042310-199506100-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199506100-00001

Search

Navigation